NCT01009203 2015-08-10Temsirolimus (Torisel®) and Erlotinib (Tarceva®) in Platinum-Refractory/Ineligible, Advanced, Squamous Cell CarcinomaNew Mexico Cancer Research AlliancePhase 2 Terminated13 enrolled 8 charts